Testosterone Cypionate/Anastrozole Injectable Recalled for Lack of Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling testosterone cypionate 200 mg/anastrozole 1.75 mg/mL injectable due to lack of assurance of sterility. The affected lot was distributed across the United States including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is a Class II drug recall involving a sterile injectable product with a documented lack of sterility assurance. Non-sterile injectables pose significant risk of serious infection and potential hospitalization, meeting the Severe criteria for Class II recalls with serious injury risk.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Testosterone Cypionate 200 mg/Anastrozole 1.75 mg/mL in oil, injectable (Rx only) due to lack of assurance of sterility. The recalled product was manufactured by Vita Pharmacy, LLC dba Talon Compounding Pharmacy, located at 2950 Thousand Oaks Drive Suite 25, San Antonio, Texas 78247.
The affected lot is T1007132021:95 with a beyond-use date (BUD) of 01/09/2022. The product is supplied in 2-vial units and was distributed throughout the United States including Washington, D.C. and Puerto Rico.
Patients who have received this product should consult their healthcare provider about appropriate follow-up care. Healthcare providers and patients with questions about this recall should contact Vita Pharmacy, LLC dba Talon Compounding Pharmacy.
The recalled product
- Product
- TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Injectable Hormone
- Hazard
- lack-of-sterility
- injectable-contamination
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: T1007132021:95 BUD: 01/09/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27